about
Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan AfricaHigh burden of prevalent and recently acquired HIV among female sex workers and female HIV voluntary testing center clients in Kigali, RwandaOutcomes of HIV-positive patients lost to follow-up in African treatment programmesTrends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning.Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in TanzaniaComprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.Mortality after failure of antiretroviral therapy in sub-Saharan Africa.Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workersSwitching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.Factors associated with late antiretroviral therapy initiation among adults in MozambiqueRetention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) CollaImprovements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination programCD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.Advanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011.Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.Risk factors for loss to follow-up prior to ART initiation among patients enrolling in HIV care with CD4+ cell count ≥200 cells/μL in the multi-country MTCT-Plus Initiative.Untangling the Relationship Between Antiretroviral Therapy Use and Incident Pregnancy: A Marginal Structural Model Analysis Using Data From 47,313 HIV-Positive Women in East Africa.A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in AfricaProgram-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes.Characteristics of HIV-Infected Children at Enrollment into Care and at Antiretroviral Therapy Initiation in Central Africa.Risk Factor Detection as a Metric of STARHS Performance for HIV Incidence Surveillance Among Female Sex Workers in Kigali, RwandaAdult HIV care resources, management practices and patient characteristics in the Phase 1 IeDEA Central Africa cohortIdentifying Perceived Barriers along the HIV Care Continuum: Findings from Providers, Peer Educators, and Observations of Provider-Patient Interactions in Ethiopia.HIV Care and Treatment Beliefs among Patients Initiating Antiretroviral Treatment (ART) in Oromia, EthiopiaFactors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in MozambiqueTuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.Expanded HIV testing coverage is associated with decreases in late HIV diagnoses.Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.Towards an integrated primary and secondary HIV prevention continuum for the United States: a cyclical process model.TB diagnostic capacity in sub-Saharan African HIV care settings.Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
P50
Q28728715-95942E03-C9E5-4C71-912E-CBE8DA8FA133Q28744694-47A26B59-6B70-4504-A468-78CF526B5BA2Q30238937-14BB7963-81D8-42B8-8424-0CF12CD13262Q30388278-7B793645-B0DB-4727-9738-2096B0D10986Q33490592-F5E4084A-DA88-433D-9D8F-31749DFD140CQ33574798-CC2C0E63-BE5A-4FEC-B569-D5BBC8C3C036Q33610946-CEB7D343-4D4F-4653-BB71-A9115D45DB9BQ33777533-9B0415D1-445B-4DE1-8150-2BAC045C5A5CQ33803701-7EB197EE-97CB-4C32-913F-52C9B3B43705Q33862806-A9E8C5AF-FA4B-4F63-8106-DE603978A55DQ33885838-48FD23C5-CE9F-443F-BEAA-690475885E35Q34208678-D721041F-740E-4F2C-B2E0-9B7EE3DFFB72Q34277766-75BAEBEE-43B3-47A6-BEEE-50EFEA72865EQ34495138-16366F8B-00B5-43B9-B8D4-31A1673D95A6Q34718675-C7B6E23A-038A-43DE-A034-BC74DEFF22C1Q34974485-F5FC8525-60CE-4AE5-B8A6-D8B4D5D6A407Q35119369-EE4EB6FD-E44A-4D18-BAD1-8591B7CEAAFAQ35180760-5702E4C9-0DAD-4AB8-AE13-04D71DDC813DQ35477959-3A45A98C-D09C-4988-A418-E07E82210ADAQ35673424-72214AD5-645A-4086-8203-5F0EE3259338Q35934094-213C9C36-D16D-4D09-A906-B3E84AFD19FBQ35963111-8ACAF2E5-E168-4F5F-885A-70627C22063AQ36175269-E4545E41-6223-42AA-A71D-0132329AAF94Q36175342-9348A350-6EAA-4276-A88D-038FCF0F4226Q36247776-639D936B-9F3F-4BAB-B170-6BA0ABAA3970Q36302106-69D26FC7-0927-409F-934B-8CA5F004EEFDQ36419116-F5001040-2B62-4F4B-9593-A412248C9EE7Q36464031-68D746F4-AE67-41F9-8409-50155C1A8F84Q36660572-F30A9583-7D34-4BB4-9FCE-E4C799FBFCE6Q36837250-EA2CAF6F-56E3-4D00-B083-49AD970E42DAQ36848380-972A98EF-791F-4644-A00A-4CA7EBDC906CQ36920997-697067A5-784A-40F5-93B3-BEAA76493854Q36942918-5023AB03-050D-4968-BDDA-DAC8CEBEEF2DQ36976947-92C0F5D3-7C49-49C9-A4C6-1F13210D976CQ37043395-5087E2DB-9BCE-4EFC-A485-D82AFE542009Q37108925-18640F92-9B3F-4649-B551-7A84F93BAF9BQ37423704-64E167C1-AF6D-477F-80CA-55CEE059E688Q37472599-E2C88B7E-50D1-4BC5-B9BB-1A9FEFCE71A9Q37473041-3FA244C5-071E-4FA8-AE09-5B85EF96FCA7Q37477423-D3B5AF66-ACE1-4D0C-8AFF-C4E883B2D984
P50
description
academicus
@nl
lecturer
@en
name
Denis Nash
@ast
Denis Nash
@en
Denis Nash
@es
Denis Nash
@nl
Denis Nash
@sq
type
label
Denis Nash
@ast
Denis Nash
@en
Denis Nash
@es
Denis Nash
@nl
Denis Nash
@sq
prefLabel
Denis Nash
@ast
Denis Nash
@en
Denis Nash
@es
Denis Nash
@nl
Denis Nash
@sq
P106
P1960
4jSjQRUAAAAJ
P2038
Denis_Nash2
P21
P31
P496
0000-0002-3280-5386